T-CELL DYSREGULATION IN PATIENTS WITH HYPERPROLACTINEMIA - EFFECT OF BROMOCRIPTINE TREATMENT

被引：63
|
作者：
VIDALLER, A
LLORENTE, L
LARREA, F
MENDEZ, JP
ALCOCERVARELA, J
ALARCONSEGOVIA, D
机构：
[1] INST NACL NUTR SALVADOR ZUBIRAN,DEPT IMMUNOL & RHEUMATOL,MEXICO CITY 14000,DF,MEXICO
[2] INST NACL NUTR SALVADOR ZUBIRAN,DEPT REPROD BIOL,MEXICO CITY 14000,DF,MEXICO
来源：
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1986年 / 38卷 / 03期
关键词：
D O I：
10.1016/0090-1229(86)90243-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：337 / 343
页数：7
相关论文
共 50 条
  • [41] DOPAMINE AGONISTS IN THE TREATMENT OF HYPERPROLACTINEMIA - COMPARISON BETWEEN BROMOCRIPTINE AND LISURIDE
    STRACKE, H
    HEINLEIN, W
    HOROWSKI, R
    SCHATZ, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1986, 36-2 (12): : 1834 - 1836
  • [42] HYPERPROLACTINEMIA IN INFERTILE THAI WOMEN, ITS INCIDENCE AND TREATMENT WITH BROMOCRIPTINE
    SRIVANNABOON, S
    ONGSANGKUL, T
    TUNGSUBUTARA, V
    MAKEMAHARN, O
    KARAVAGUL, C
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1985, 68 (12): : 638 - 642
  • [43] Infliximab treatment improves PML in sarcoidosis patients with T cell dysregulation
    Rosenkranz, S. C.
    Thom, V.
    Willing, A.
    Kolster, M.
    Tolosa, E.
    Friese, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 859 - 859
  • [44] THE EFFECTS OF PROLONGED BROMOCRIPTINE ADMINISTRATION ON GLYCEMIC CONTROL IN PATIENTS WITH HYPERPROLACTINEMIA
    Danciulescu Miulescu, Rucsandra
    Trifanescu, Raluca
    Carsote, Mara
    Paun, Sorin
    Culman, Mirela
    Sfetea, Roxana Corina
    Margina, Denisa
    Poiana, Catalina
    INTERDIAB 2016: DIABETES MELLITUS AS CARDIOVASCULAR DISEASE, 2016, : 195 - 200
  • [45] Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients
    Shu Zhao
    Liangyu Zhang
    Minghui Zhang
    Guodong Yao
    Xiaosan Zhang
    Wenhui Zhao
    Wei Ren
    Jingxuan Wang
    Qingyuan Zhang
    Medical Oncology, 2012, 29 : 2311 - 2316
  • [46] Angioimmunoblastic T-cell lymphoma: the effect of initial treatment and microvascular density in 31 patients
    Zhao, Shu
    Zhang, Liangyu
    Zhang, Minghui
    Yao, Guodong
    Zhang, Xiaosan
    Zhao, Wenhui
    Ren, Wei
    Wang, Jingxuan
    Zhang, Qingyuan
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2311 - 2316
  • [47] Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia -: A case report
    Bliesener, N
    Yokusoglu, H
    Quednow, BB
    Kingmüller, D
    Kühn, KU
    PHARMACOPSYCHIATRY, 2004, 37 (04) : 189 - 191
  • [48] TREATMENT OF TYPE-III HYPERLIPOPROTEINEMIA WITH BROMOCRIPTINE IN A PREMENOPAUSAL WOMAN WITH HYPERPROLACTINEMIA
    STOCK, JL
    HIGANO, N
    ROBINSON, RW
    HAAS, R
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (04): : 761 - 762
  • [49] DELAYED PUBERTY AND HYPOPLASTIC UTERUS ASSOCIATED WITH HYPERPROLACTINEMIA - SUCCESSFUL TREATMENT WITH BROMOCRIPTINE
    KAULI, R
    SCHOENFELD, A
    OVADIA, Y
    MATH, S
    ASSA, S
    LARON, Z
    HORMONE RESEARCH, 1985, 22 (1-2) : 68 - 73
  • [50] LONG-ACTING ORAL BROMOCRIPTINE (PARLODEL SRO) IN THE TREATMENT OF HYPERPROLACTINEMIA
    WEINGRILL, CO
    MUSSIO, W
    MORAES, CRS
    PORTES, E
    CASTRO, RC
    LENGYEL, AMJ
    FERTILITY AND STERILITY, 1992, 57 (02) : 331 - 335
12345